These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10727296

  • 1. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors.
    Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K, Mulligan R, Thorpe PE, Dvorak HF, Dvorak AM.
    J Histochem Cytochem; 2000 Apr; 48(4):545-56. PubMed ID: 10727296
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF, Tognazzi K, Dvorak HF, Harrist TJ.
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
    Feng D, Nagy JA, Dvorak AM, Dvorak HF.
    Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.
    Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM.
    J Exp Med; 1996 May 01; 183(5):1981-6. PubMed ID: 8642308
    [Abstract] [Full Text] [Related]

  • 9. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.
    Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM.
    Curr Top Microbiol Immunol; 1999 May 01; 237():97-132. PubMed ID: 9893348
    [Abstract] [Full Text] [Related]

  • 10. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM.
    J Clin Invest; 1996 Jan 15; 97(2):469-76. PubMed ID: 8567969
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
    Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ, Kerjaschki D, Bueler H, Ylä-Herttuala S, Alitalo K.
    FASEB J; 2002 Jul 15; 16(9):1041-9. PubMed ID: 12087065
    [Abstract] [Full Text] [Related]

  • 13. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium.
    Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM.
    J Histochem Cytochem; 2004 Jan 15; 52(1):87-101. PubMed ID: 14688220
    [Abstract] [Full Text] [Related]

  • 14. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K.
    EMBO J; 1996 Jan 15; 15(2):290-98. PubMed ID: 8617204
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T.
    J Mol Cell Cardiol; 1999 Mar 15; 31(3):607-17. PubMed ID: 10198191
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF.
    Cancer; 1996 Aug 01; 78(3):454-60. PubMed ID: 8697391
    [Abstract] [Full Text] [Related]

  • 17. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.
    Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR.
    Carcinogenesis; 1997 Jun 01; 18(6):1155-61. PubMed ID: 9214597
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
    Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L.
    J Immunol; 1995 Mar 15; 154(6):2801-7. PubMed ID: 7876550
    [Abstract] [Full Text] [Related]

  • 19. Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites.
    Simon M, Röckl W, Hornig C, Gröne EF, Theis H, Weich HA, Fuchs E, Yayon A, Gröne HJ.
    J Am Soc Nephrol; 1998 Jun 15; 9(6):1032-44. PubMed ID: 9621286
    [Abstract] [Full Text] [Related]

  • 20. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 15; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.